| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $10.32M | $2.82M | $21.05M | $13.54M | $10.14M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $146.14M | $137.64M | $114.51M | $80.17M | $58.78M |
| R&D | $114.15M | $107.35M | $88.15M | $59.82M | $44.95M |
| SG&A | $31.99M | $30.29M | $26.35M | $20.35M | $13.83M |
| Operating Income | -$135.81M | -$134.82M | -$93.46M | -$66.64M | -$48.64M |
| Interest Expense | $2.77M | $3.65M | $3.76M | $1.18M | – |
| Tax Expense | $0.00 | – | – | – | – |
| Net Income | -$129.77M | -$127.50M | -$89.22M | -$66.22M | -$48.63M |
| EPS (basic) | -1.0000 | -1.1400 | -1.3600 | -2.7500 | -4.1700 |
| EPS (diluted) | -1.0000 | -1.1400 | -1.3600 | -2.7500 | -4.1700 |
| Shares (diluted) | $129.78M | $111.99M | $65.60M | $24.05M | $11.66M |